GenScript Biotech Corporation, a global leader in life sciences services and products, has announced the establishment of new operations site and logistics center in Sydney, Australia.

This strategic expansion represents a significant milestone in GenScript's continued commitment to supporting the rapid growth of the biotechnology sector in Australia. It also underscores the company's determination to strengthen GenScript's presence in the Asia-Pacific region and globally, advancing innovative solutions that address the evolving needs of the industry.

The new Sydney facility will significantly enhance GenScript's ability to serve customers across the region, ensuring faster and more efficient delivery of research reagents and products.

With a local presence, Australian researchers and biotech companies will no longer need to navigate the complexities of permit applications, customs clearance, and tax payments, streamlining the procurement process, and allowing them to focus on advancing their groundbreaking research and innovation.

A key highlight of the Sydney site is the introduction of next-day shipping for high-demand products such as off-the-shelf mRNA, growth factors, Cas proteins, and more. This expedited service ensures that researchers and biotech companies can access essential materials with unprecedented speed, accelerating their scientific discoveries and development efforts.